|
|
|
Volumn 1, Issue 2, 2002, Pages 127-131
|
|
Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CLOBETASOL;
GLUCOCORTICOID;
PHENYLALANINE;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
ORAL DRUG ADMINISTRATION;
PUVA;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
VITILIGO;
ADMINISTRATION, ORAL;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS;
CLOBETASOL;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
MALE;
PHENYLALANINE;
PUVA THERAPY;
TREATMENT OUTCOME;
VITILIGO;
|
|
EID: 0037824389
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
